Modelling extracellular domains of GABA-A receptors: Subtypes 1, 2, 3, and 5

Biochemical and Biophysical Research Communications

Volumn 316, Issue 3, 2004, Pages 636-642

  Chou, Kuo Chen ^a,b  

^a Tianjin Inst Bioinfo Drug Discov   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

1,2,3,5 2 interfaces; 1,2,3,5 2 interfaces; Benzodiazepine binding site; Benzodiazepine pharmacology; GABAergic inhibition; Ligand gated chloride channel

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; LIGAND; RECEPTOR SUBTYPE;

ARTICLE; COMPUTER MODEL; DRUG BINDING; DRUG SELECTIVITY; DRUG SPECIFICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BENZODIAZEPINES; CHLORIDES; CYTOPLASM; DISULFIDES; ELECTROPHYSIOLOGY; HUMANS; LIGANDS; LIPID BILAYERS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MODELS, THEORETICAL; MOLECULAR SEQUENCE DATA; MOLLUSCA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GABA-A;

MAMMALIA;

EID: 1642377868     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.098     Document Type: Article

References (32)

1. Gunther U., Benson J., Benke D., Fritschy J.M., Reyes G., Knoflach F., Crestani F., Aguzzi A., Arigoni M., Lang Y. Proc. Natl. Acad. Sci. USA. 92:1995;7749-7753.
2. Wieland H.A., Luddens H., Seeburg P.H. J. Biol. Chem. 267:1992;1426-1429.
3. McKernan R.M., Whiting P.J. Trends Neurosci. 19:1996;139-143.
4. Mohler H., Fritschy J.M., Rudolph U. J. Pharmacol. Exp. Ther. 300:2002;2-8.
5. Sigel E., Buhr A. Trends Pharmacol. Sci. 18:1997;425-429.
6. Klausberger T., Fuchs K., Mayer B., Ehya N., Sieghart W. J. Biol. Chem. 275:2000;8921-8928.
7. Baumann S.W., Baur R., Sigel E. J. Biol. Chem. 276:2001;36275-36280.
8. Tretter V., Ehya N., Fuchs K., Sieghart W. J. Neurosci. 17:1997;2728-2737.
9. Schofield P.R., Pritchett D.B., Sontheimer H., Kettenmann H., Seeburg P.H. FEBS Lett. 244:1989;361-364.
10. Wingrove P., Hadingham K., Wafford K., Kemp J.A., Ragan C.I., Whiting P. Biochem. Soc. Trans. 20:1992;18S.
11. Hadingham K.L., Wingrove P., Le Bourdelles B., Palmer K.J., Ragan C.I., Whiting P.J. Mol. pharmacol. 43:1993;970-975.
12. McKinley D.D., Lennon D.J., Carter D.B. Brain Res. Mol. Brain Res. 28:1995;175-179.
13. Pritchett D.B., Sontheimer H., Shivers B.D., Ymer S., Kettenmann H., Schofield P.R., Seeburg P.H. Nature. 338:1989;582-585.
14. Thompson J.D., Higgins D.G., Gibson T.J. Nucleic Acids Res. 22:1994;4673-4680.
15. Chou K.C. Curr. Protein Peptide Sci. 3:2002;615-622.
16. Chou K.C. Protein Eng. 14:2001;75-79.
17. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van der Oost J., Smit A.B., Sixma T.K. Nature. 411:2001;269-276.
18. Jones T.A., Thirup S. EMBO J. 5:1986;819-822.
19. Blundell T.L., Sibanda B.L., Sternberg M.J.E., Thornton J.M. Nature (London). 326:1987;347-352.
20. Chou K.C., Nemethy G., Pottle M., Scheraga H.A. J. Mol. Biol. 205:1989;241-249.
21. Finzel B.C., Kimatian S., Ohlendorf D.H., Wendoloski J.J., Levitt M., Salemme F.R. Bugg C.E., Ealick S.E. Crystallographic and Modeling Methods in Molecular Design. 1989;175-188 Springer-Verlag, Berlin.
22. Levitt M. J. Mol. Biol. 226:1992;507-533.
23. Chou K.C., Jones D., Heinrikson R.L. FEBS Lett. 419:1997;49-54.
24. Watt W., Koeplinger K.A., Mildner A.M., Heinrikson R.L., Tomasselli A.G., Watenpaugh K.D. Structure. 7:1999;1135-1143.
25. Chou J.J., Matsuo H., Duan H., Wagner G. Cell. 94:1998;171-180.
26. Chou K.C., Watenpaugh K.D., Heinrikson R.L. Biochem. Biophys. Res. Commun. 259:1999;420-428.
27. Chou K.C., Tomasselli A.G., Heinrikson R.L. FEBS Lett. 470:2000;249-256.
28. Chou K.C., Howe W.J. Biochem. Biophys. Res. Commun. 292:2002;702-708.
29. Chou K.C. J. Protein Chem. 12:1993;337-350.
30. Chou K.C. Amino Acids. 7:1994;1-17.
31. Buhr A., Sigel E. Proc. Natl. Acad. Sci. USA. 94:1997;8824-8829.
32. Renard S., Olivier A., Granger P., Avenet P., Graham D., Sevrin M., George P., Besnard F. J. Biol. Chem. 274:1999;13370-13374.